Pacific Biosciences Prices $86.9M Public Stock Offering
The sequencing firm is offering 19.4 million shares of common stock at $4.47 per share and plans to use the proceeds for product launches, among other uses.
HTG Molecular Diagnostics Files for $20M Stock Offering
The Tucson, Arizona-based company previously raised $20 million through a public offering of its shares and a purchase deal with certain investors.
Cantor Fitzgerald Downgrades PerkinElmer to Neutral
The investment bank, which maintained its $60 price target for the company's stock, said it is looking for signs of revenue acceleration.
Cantor Fitzgerald Initiates Coverage on Rosetta Genomics, Veracyte
The investment bank initiated coverage on Rosetta Genomics and Veracyte, rating the molecular diagnostic firms' shares speculative buy and buy, respectively.
Cancer Genetics, Cantor Fitzgerald Reach $20M Stock Sales Agreement
The company also said that its cash burn rate for Q2 is estimated to be about $4.8 million, or $1.3 million more than its average cash burn.